Homepage3692 • HKG
add
Hansoh Pharmaceutical Group Company Ltd
Vorige slotkoers
$Â 38,74
Dag-range
$Â 38,02 - $Â 39,56
Jaar-range
$Â 21,40 - $Â 44,22
Beurswaarde
238,68Â mld. HKD
Gem. volume
10,77Â mln.
Koers/winst
36,91
Dividendrendement
1,10%
Primaire beurs
HKG
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 3,80Â mld. | 31,96% |
Bedrijfskosten | 2,25Â mld. | 14,95% |
Netto inkomsten | 1,21Â mld. | 47,03% |
Netto winstmarge | 31,87 | 11,43% |
Winst per aandeel | — | — |
EBITDA | 1,22Â mld. | 65,03% |
Effectief belastingtarief | 15,44% | — |
Balans
Totale activa
Totale passiva
| (CNY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 31,57Â mld. | 34,79% |
Totale activa | 39,90Â mld. | 26,04% |
Totale passiva | 4,54Â mld. | 52,32% |
Totaal aandelenvermogen | 35,36 mld. | — |
Uitstaande aandelen | 5,99 mld. | — |
Koers-boekwaardeverhouding | 6,55 | — |
Rendement op activa | 7,04% | — |
Rendement op kapitaal | 7,92% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 1,21Â mld. | 47,03% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Opgericht
1995
Website
Werknemers
9.347
